- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT03670277
Evaluation of On-eye Optical Performances of the RMY-100 Lens
Studieöversikt
Status
Betingelser
Intervention / Behandling
Studietyp
Inskrivning (Faktisk)
Fas
- Inte tillämpbar
Kontakter och platser
Studieorter
-
-
Ontario
-
Waterloo, Ontario, Kanada
- Centre for Ocular Research & Education
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
Potential subjects must satisfy all of the following criteria to be enrolled in the study:
- Pediatric subjects (<18 years old) must read (or be read to), understand, and sign the Statement of Information and Assent and receive a fully executed copy of the form.
- Adult subjects (≥18 years old) and parent(s) or legal guardian(s) of pediatric subjects must read, understand and sign the Statement of Informed Consent and receive a fully executed copy of the form.
- Appear able and willing to adhere to the instructions set forth in this clinical protocol.
- Between 7 and 25 years of age (inclusive).
- Have normal eyes (i.e., no ocular medications or infections of any type).
- Vertex-corrected distance subjective best-sphere refraction must be between -1.00D and -5.00D (inclusive) in each eye.
- Cylindrical refraction must be 1.00D or less in each eye, by subjective sphero-cylindrical refraction.
Have sphero-cylindrical best-corrected visual acuity of 20/25 or better in each eye.
Below inclusion criterion is for subjects to be enrolled to the Control group only:
Are existing orthokeratology patients whose current treatment has been stabilized for at least 1 months and with complete pre-treatment record, e.g., spherocylindrical refraction and corneal topography. Pre-treatment wavefront aberration measures are preferred by not required.
Exclusion Criteria:
Potential subjects who meet any of the following criteria will be excluded from participating in the study:
- Currently pregnant or lactating.
- Any systemic allergies, infectious disease (e.g., hepatitis, tuberculosis), autoimmune disease (e.g., rheumatoid arthritis), or other diseases, by self-report, which are known to interfere with contact lens wear and/or participation in the study.
- Use of systemic medications (e.g., chronic steroid use) that are known to interfere with contact lens wear and/or participation in the study.
- Any current use of ocular topical medication (occasional use of re-wetting drops is allowed).
- Any previous or planned ocular or intraocular surgery, including refractive surgery.
- Participation in any contact lens or lens care product clinical trial within 7 days prior to study enrollment.
- Employee or their children/relatives of investigational clinic (e.g., Investigator, Coordinator, Technician). 8 . Any ocular allergies, infections or other ocular abnormalities that are known to interfere with contact lens wear and/or participation in the study. This may include, but not be limited to, aphakia, uveitis, ocular hypertension, glaucoma, severe keratoconjunctivitis sicca, history of recurrent corneal erosions, keratoconus, keratoconus suspect, pellucid marginal degeneration, entropion, ectropion, extrusions, chalazia, and recurrent styes.
9 . Any Grade 3 or greater slit lamp findings (eg, edema, corneal neovascularization, corneal staining, tarsal abnormalities, and conjunctival injection) on the FDA scale.
10 . Any ocular abnormality that is contraindicated contact lens wear. 11 . Any corneal scar within central 5mm 12 . Binocular vision abnormality, intermittent strabismus or strabismus. Below exclusion criteria are for subjects to be enrolled to the Test group only 13 . Current or recent (within 30 days from enrollment) rigid lens wearers. 14 . History of orthokeratology treatment. 15. Any corneal distortion resulting from ocular diseases or previous hard or rigid gas permeable contact lens wear.
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Behandling
- Tilldelning: Icke-randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
---|---|
Experimentell: TEST arm
For subjects enrolled in the Test arm, the Test Soft Contact Lens will be bilaterally fitted to the subject's eyes.
Endpoint measures will be collected over one eye only - Test Arm: OD only.
|
Test Soft Contact Lens
|
Experimentell: CONTROL arm
Subjects enrolled in the Control Arm will be established orthokeratology lens wearers.
Endpoint measures will be collected over one eye only - Control Arm: Better OK fitted eyes based on investigator's judgement.
|
CONTROL
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Distance Spherical Aberration (Z4, 0)
Tidsram: Up to Post Lens Fitting Evaluation
|
Spherical aberration (Z4, 0) for a 5-mm pupil was measured by an aberrometer (COAS by AMO) with a distant viewing target at 4 m at the Baseline and post lens fitting.
The Control Group only had 1 study Visit that record Baseline measurements, no intervention from the sponsor was implemented for this group, therefore data was collected on a bare eye.
The Test group was fitted with the study lens at Visit 2 and data was collected with the Test lens on eye.
|
Up to Post Lens Fitting Evaluation
|
Near Spherical Aberration (Z4, 0)
Tidsram: Up to Post Lens Fitting Evaluation
|
Spherical aberration (Z4, 0) for a 5 mm pupil was measured by an aberrometer (COAS by AMO) with a near view target at 25 cm.
at the Baseline and post lens fitting.
The Control Group only had 1 study Visit that record Baseline measurements, no intervention from the sponsor was implemented for this group, therefore data was collected on a bare eye.
The Test group was fitted with the study lens at Visit 2 and data was collected with the Test lens on eye.
|
Up to Post Lens Fitting Evaluation
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Distance Off-axis Refraction at ±10°, ±20°, and ±30° Retinal Eccentricities.
Tidsram: Up to Post Lens Fitting Evaluation
|
Distance off-axis refractions were measured by an open-field autorefractor (WAM-5500 by Grand Seiko) with distant viewing targets at 4 m and ±10°, ±20°, and ±30° off axis. at the Baseline and post lens fitting.
The Control Group only had 1 study Visit that record Baseline measurements, no intervention from the sponsor was implemented for this group, therefore data was collected on a bare eye.
The Test group was fitted with the study lens at Visit 2 and data was collected with the Test lens on eye.
|
Up to Post Lens Fitting Evaluation
|
Near Off-axis Refraction at ±30° Retinal Eccentricities.
Tidsram: Up to Post Lens Fitting Evaluation
|
Near off-axis refractions were measured by an open-field autorefractor (WAM-5500 by Grand Seiko) with near viewing targets at 25 cm and ±30° off-axis.
at the Baseline and post lens fitting.
The Control Group only had 1 study Visit that record Baseline measurements, no intervention from the sponsor was implemented for this group, therefore data was collected on a bare eye.
The Test group was fitted with the study lens at Visit 2 and data was collected with the Test lens on eye.
|
Up to Post Lens Fitting Evaluation
|
Samarbetspartners och utredare
Utredare
- Studiestol: Xu Cheng, Johnson & Johnson Vision Care, Inc.
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Faktisk)
Avslutad studie (Faktisk)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Andra studie-ID-nummer
- CR-6000
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
produkt tillverkad i och exporterad från U.S.A.
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på Synskärpa
-
VisiblyRekryteringDigital Acuity produktFörenta staterna
-
Benha UniversityAvslutad
-
Zhongshan Ophthalmic Center, Sun Yat-sen UniversityRekryteringVisual Health of Virtual RealityKina
-
University of Illinois at Urbana-ChampaignAvslutadKognitiv förändring | Bearbetning, Visual SpatialFörenta staterna
-
New York City Health and Hospitals CorporationAvslutadGlaukom | Näthinnesjukdom | Visual Pathway DisorderFörenta staterna
-
Neuro-Eye Diagnostic Systems, LLCNeuro-ophthalmology of Texas PLLCAnmälan via inbjudanMakulasjukdom | Visual Pathway Disorder | SynnervssjukdomFörenta staterna
-
University of Illinois at Urbana-ChampaignAvslutadKognitiv förändring | Fungerande minne | Hämning (psykologi) | Bearbetning, Visual SpatialFörenta staterna
-
University of ZurichUSZ FoundationAktiv, inte rekryterande
-
Korea University Anam HospitalKorea UniversityAvslutadSmärtmätning | Visual Analog Pain Scale
Kliniska prövningar på etafilcon A
-
Johnson & Johnson Vision Care, Inc.Avslutad
-
Johnson & Johnson Vision Care, Inc.Avslutad
-
Johnson & Johnson Vision Care, Inc.AvslutadSynskärpaFörenta staterna
-
Johnson & Johnson Vision Care, Inc.AvslutadMyopiFörenta staterna
-
Johnson & Johnson Vision Care, Inc.Avslutad
-
Johnson & Johnson Vision Care, Inc.Visioncare Research Ltd.; Johnson & Johnson K.K. Medical CompanyAvslutad
-
Johnson & Johnson Vision Care, Inc.Avslutad
-
Johnson & Johnson Vision Care, Inc.Avslutad
-
Coopervision, Inc.Avslutad